ASCO 2015 Highlights

Foundation Medicine on a Molecular Level
Foundation Medicine on a Molecular Level
By Gary Palmer, MD
Personalized Medicine
Videos
Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.
Read Article
Personalizing Cancer Treatment Based on a Unique Genetic Profile
Personalizing Cancer Treatment Based on a Unique Genetic Profile
By Gary Palmer, MD
Personalized Medicine
Videos
Gary Palmer, MD, explains how research is ahead of the physician and patient and the need to educate the physician and patient on all the information about DNA and what drives the cancer.
Read Article
Is Research Translating to Meaningful Treatment to Patients?
Is Research Translating to Meaningful Treatment to Patients?
By Gary Palmer, MD
Personalized Medicine
Videos
Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.
Read Article
How to Better Establish Clinical Utility for Tests in Personalized Medicine
How to Better Establish Clinical Utility for Tests in Personalized Medicine
By Gary Palmer, MD
Personalized Medicine
Videos
Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.
Read Article
Value-Based Concerns for Oncologists in the US
Value-Based Concerns for Oncologists in the US
By Gary Palmer, MD
Pricing
Videos
Dr. Palmer talks about healthcare cost and the affect it has on an oncologist.
Read Article
Oncologists and Cost Issues
Oncologists and Cost Issues
By Michael Kolodziej, MD
Pricing
Videos
Dr. Palmer touches base on the importance of oncologists and consideration of cost issues, and gives a sense of how this impacts the healthcare system.
Read Article
Foundation Medicine and Other Categories
Foundation Medicine and Other Categories
By Gary Palmer, MD
Practice Management, Value Peer-spectives
Videos
Gary Palmer, MD, speaks about all the applications of Foundation Medicine and its value in diseases other than cancer.
Read Article
Patients and Treatment Discussions
Patients and Treatment Discussions
By Gary Palmer, MD
Personalized Medicine
Videos
Dr. Gary Palmer explains the importance of patients having choices and the need to be involved in all discussions on treatment options.
Read Article
CLEOPATRA: Record-Breaking Survival in HER2 Metastatic Breast Cancer by Adding Pertuzumab
By Phoebe Starr
ESMO 2014 Highlights, ESMO
October 2014, Vol 5 , No 8
Madrid, Spain—Final results from the CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) trial show that dual HER2 blockade with the combination of pertuzumab and trastuzumab plus chemotherapy extended overall survival (OS) by almost 16 months compared with trastuzumab plus chemotherapy alone in patients with HER2-positive metastatic breast cancer.
Read Article
Medicaid Reimbursement Rate Has Direct Impact on Cancer Screening Rates
By Rosemary Frei, MSc
Economics & Value, Economics of Cancer Care
October 2014, Vol 5 , No 8
Although increasing the reimbursement rate for cancer screening tests does not consistently improve the likelihood of Medicaid beneficiaries being screened for cancer, raising the rate of reimbursement for office visits does consistently increase the likelihood that they will be screened for cancer, including breast or prostate cancer, according to results of a new analysis of Medicaid claims and enrollment data (Halpern MT, et al. Cancer. 2014 Aug 25. Epub ahead of print).
Read Article

Page 210 of 330

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.